Cigna Group

Held by 3 specialist biotech funds

High Convergence

Share on X

Fund Holdings

3 fund convergence

Casdin Capital OrbiMed Advisors Deerfield Management

Catalysts

No catalysts tracked.

Position Details

Casdin CapitalNEWFeb 17, 2026

Shares: 40,000Value: $11.0M

# Signal Note: Casdin Capital Initiates CI Position Casdin's $11M entry into Cigna represents notable validation of the insurer's strategic positioning in pharmacy benefits management (PBM) and specialty drug distribution—particularly relevant given ongoing regulatory scrutiny of PBM rebate practices and potential margin compression. The timing suggests confidence in CI's ability to navigate 2024-25 healthcare policy headwinds, though the position size is modest relative to Casdin's typical genomics/tools focus, suggesting this may be a macro healthcare bet rather than a precision medicine-specific thesis.

OrbiMed AdvisorsNEW

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

ALNY3 funds SPRY3 funds GPCR3 funds RVMD3 funds RNA2 funds IRON2 funds PRAX2 funds EWTX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

AI Signal

AI analyst context — unlock full analysis

# Signal Note: OrbiMed Initiates $56.4M Position in Cigna Group **Why it matters:** OrbiMed's entry into CI signals conviction in the health insurance sector's valuation or operational trajectory, likely reflecting confidence in Cigna's pharmacy benefits management (PBM) division and medical cost management amid ongoing GLP-1 adoption tailwinds and consolidation dynamics. The $56.4M stake size (~0.7% of market cap) suggests a core conviction rather than opportunistic bet, potentially betting on margin expansion as PBM scale improves or cost inflation moderates.